CareFusion issues pair of recalls, increases "recall reserve" fund by $7M
CareFusion adds an extra $7 million to its "recall reserve" amid a pair of recalls affecting some AirLife infant breathing circuits and certain Alaris infusion pumps.
CareFusion (NYSE:CFN) issued a pair of recalls involving its AirLife infant breathing circuits and certain Alaris infusion pumps, in the process adding $7 million to its "recall reserve" for the 2nd quarter.
The San Diego-based device maker recalled certain lots of its AirLife infant breathing circuits after receiving reports that the Y-shaped adapters may be prone to cracking, creating leaks in the closed ventilation system.
One such incident reported to the FDA's MAUDE adverse event report database in April noted that the Y-adapters had cracked in 5 different cases, but there had been no known harm to patients.